Liraglutide

Liraglutide is a modified GLP-1 analogue studied for sustained GLP-1 receptor activation.

Metabolic Research

Select specification 3 listed

Specification: 5mg × 10 vials
Catalog code: LIR5
Material category: Peptide

Choose a contact to discuss this specification, quantity or customization.

Testing in ProgressReport Pending

For laboratory research use only. Not for human use.

The research context

A closer look at Liraglutide.

GLP-1 receptor signaling and metabolic regulation

Technical Details Product information

Liraglutide parent

CAS: 204656-20-2
formula: C172H265N43O51
mass: 3751.25

Liraglutide solubility

solubility: DMSO 100 mg/mL (26.65 mM)

Liraglutide — MCE material and storage

CAS: 204656-20-2
formula: C172H265N43O51
mass: 3751.20
sequence: HAEGTFTSDVSSYLEGQAA-{Lys(gamma-Glu-C16 acid)}-EFIAWLVRGRG

Storage: Powder -80°C for 2 years or -20°C for 1 year. Solution -80°C for 6 months or -20°C for 1 month. Sealed, protected from light and moisture.

FAQ

Liraglutide questions

What is Liraglutide?

Liraglutide is a modified GLP-1 analogue studied for sustained GLP-1 receptor activation.

Which specifications and packs are listed?

5mg × 10 vials; 10mg × 10 vials; 30mg × 10 vials.

Can I request a different specification?

Yes. Contact our team on WhatsApp or Telegram to discuss specifications and customization.

Where can I view its COA?

This product is undergoing testing. Its COA will be added when available.

Let's discuss your specification

Make Liraglutide part of your project.

Your enquiry includes the selected specification and catalog code.